|
PRINT COMPANY INFORMATION
| Market Information: |
| Last Trade: |
215.50 |
| Last Update |
Jun 19, 2013 at 02:31PM |
| Change |
|
| |
|
| Open Price |
207.0 |
| Adjusted Open Price |
206.7 |
| Yesterday Close Price |
206.7 |
|
| |
| Close Price |
217.1 |
| |
|
| Day's Range |
207.0 - 218.5 |
| |
|
| Volume |
1230520 |
| |
|
| Total Trade |
5784 |
| |
|
| Market Cap in BDT* |
76637.883 (mn) |
|
| |
|
|
|
| Basic Information: |
|
|
|
| Authorized Capital in BDT* (mn) |
5000.0 |
|
|
| Paid-up
Capital in BDT* (mn) |
3708.0 |
52 Week's Range |
162.8 - 265.5 |
| |
|
|
|
| Face Value |
10.0 |
Market Lot |
10 |
| |
|
|
|
| Total no. of Securities |
370768664 |
Business Segment |
Pharmaceuticals & Chemicals |
|
VIEW CLOSE PRICE GRAPH FOR
LAST ONE MONTH
LAST ONE YEAR
VIEW TOTAL TRADES GRAPH FOR
LAST ONE MONTH
LAST ONE YEAR
| Last AGM Held: 25/09/2012 |
| Bonus Issue |
40% 2012, 35% 2011, 30% 2010, 25% 2009, 35% 2008, 50% 2007, 20%2006, 15% 2005, 20% 2004,20% 2003, 20% 2002, 25% 96 |
| |
|
| Right Issue |
|
| |
|
| Year End |
201203 |
| |
|
| Reserve & Surplus in BDT* (mn) |
13376.9 |
|
| Interim
Financial Performance: 2012 |
Particulars |
Unaudited
/ Audited |
| Q1(3 Months)
|
Q2(6 Months)
|
Q3(9 Months)
|
Q4 (12 Months)
|
|
201206 |
201209 |
201212 |
|
Turn Over in BDT* (mn)
|
4258.22 |
9349.28 |
14661.03 |
n/a |
Net Profit After Tax in BDT *(mn) (Continuing Operations)
|
982.98 |
2050.76 |
3245.1 |
n/a |
| Net
Profit After Tax in BDT *(mn)
(Including Extra-ordinary Income) |
0 |
0 |
0 |
n/a |
Basic EPS in BDT*
(Based on continuing operations) |
3.710 |
5.530 |
8.750 |
n/a |
Diluted EPS in BDT* (Based on continuing
operations) |
|
2.650 |
0.000 |
0.000 |
n/a |
Basic
EPS in BDT*
(Including Extra-ordinary Income) |
0.000 |
0.000 |
0.000 |
n/a |
Diluted EPS in BDT* (Including Extra-ordinary Income) |
|
0.000 |
0.000 |
0.000 |
n/a |
|
Profit Status :
| |
Basic |
Diluted |
Current Price Earning Ratio (P/E)
(Based on Continuing operation)
|
18.61 |
|
Current Price Earning Ratio (P/E)
(Including Extra-ordinary Income) |
|
|
* Note - Based on Annualized
EPS of 2012 (Q3)
Price Earning Ratio Based
on last Audited Financials:
Current Price Earning Ratio (P/E)
(Based on Continuing Operation)
|
22.24 |
Current Price Earning Ratio (P/E)
(Including Extra-ordinary Income) |
|
* Note - Based on
audited EPS of 2012
| Year |
Basic
EPS |
Basic
EPS (restated) |
Net Asset Value Per Share |
Restated
Net Asset Value Per Share |
Net Profit After Tax (mn) |
| Based on |
Based on |
| Continuing operations |
Including
Extra-Ordinary Income |
Continuing operations |
Including Extra-Ordinary
Income |
Continuing operations |
Including Extra-Ordinary
Income |
| 2000 |
167.26 |
n/a |
n/a |
n/a |
871.24 |
n/a |
418.25 |
n/a |
| 2001 |
229.47 |
n/a |
n/a |
n/a |
1030.71 |
n/a |
573.68 |
n/a |
| 2002 |
303.78 |
n/a |
n/a |
n/a |
1107.90 |
n/a |
759.45 |
n/a |
| 2003 |
254.96 |
n/a |
n/a |
n/a |
1086.42 |
n/a |
764.88 |
n/a |
| 2004 |
269.46 |
n/a |
n/a |
n/a |
1295.04 |
n/a |
970.04 |
n/a |
| 2005 |
290.71 |
n/a |
n/a |
n/a |
1304.07 |
n/a |
1255.85 |
n/a |
| 2006 |
234.67 |
n/a |
n/a |
n/a |
1288.65 |
n/a |
1165.86 |
n/a |
| 2007 |
218.61 |
n/a |
n/a |
n/a |
1280.08 |
n/a |
1303.24 |
n/a |
| 2008 |
n/a |
n/a |
114.47 |
n/a |
n/a |
697.22 |
1381.86 |
n/a |
| 2009 |
170.51 |
n/a |
136.40 |
n/a |
905.05 |
724.04 |
2058.38 |
n/a |
| 2010 |
165.48 |
n/a |
127.29 |
n/a |
857.52 |
659.63 |
2497.12 |
n/a |
| 2011 |
16.605 |
n/a |
12.3 |
n/a |
81.375 |
60.278 |
3257.48 |
n/a |
| 2012 |
13.66 |
n/a |
9.76 |
n/a |
72.20 |
51.57 |
3618.57 |
n/a |
|
|
All figures in BDT (Bangladeshi Taka) |
| Financial Performance (Continue): |
| Year |
Year End P/E |
% Dividend |
% Dividend Yield |
| Based on |
| Continuing operations |
Including
Extra-Ordinary Income |
| 2000 |
8.33 |
n/a |
65.00 |
4.67 |
| 2001 |
5.52 |
n/a |
70.00 |
7.50 |
| 2002 |
4.09 |
n/a |
75.00,20%B |
6.04 |
| 2003 |
7.14 |
n/a |
70.00,20%B |
3.85 |
| 2004 |
16.45 |
n/a |
70.00,20%B |
1.58 |
| 2005 |
10.97 |
n/a |
77.00,15%B |
2.42 |
| 2006 |
9.32 |
n/a |
75.00,20%B |
3.43 |
| 2007 |
11.20 |
n/a |
50.00,50%B |
2.04 |
| 2008 |
35.90 |
n/a |
40.00, 35%B |
0.97 |
| 2009 |
23.44 |
n/a |
40.00, 25%B |
1.36 |
| 2010 |
28.13 |
n/a |
35%, 30%B |
0.98 |
| 2011 |
26.60 |
n/a |
30.00, 35%B |
0.92 |
| 2012 |
24.31 |
n/a |
25.00, 40%B |
1.05 |
|
| Details of Financial Statement |
|
| Price Sensitive Information |
|
| Other Information of the Company: |
| Listing Year |
1995 |
| |
|
| Market Category |
A |
| |
|
| Electronic Share |
Y |
| |
|
| Share Percentage: |
| Sponsor/Director 54.23 |
Govt.0 |
Institute 16.95 |
Foreign 7.98 |
Public 20.84 |
|
| Remark |
1. The Face Value of the securities has been changed into TK 10. The No. of Shares, Market Lot, EPS, NAV and DPS have been changed accordingly. |
|
| Address of the Company: |
| Address: |
Square Centre, 48, Mohakhali C/A, Dhaka - 1212 |
| |
|
| Contact Phone: |
8833047-56, 8859007 |
| |
|
| Fax: |
88 - 02 - 8828768 |
| |
|
| E-mail: |
info@squaregroup.com |
| Web Address: |
http://www.squarepharma.com.bd
|
|
* BDT - Bangladeshi Taka
STOCK EXCHANGE BUILDING, 9/F MOTIJHEEL C/A, DHAKA BANGLADESH
Phone: 88-02-9564601, 7175703-11, FAX: +88-02-9564727
Email: dse@bol-online.com, Web: http://www.dsebd.org/
|
 |